A Targeted Biotech ETF Is Brushing Off the Selling
February 27, 2020 at 16:29 PM EST
Among the ares of the market that escaped the ongoing bloodshed on Wednesday, a biotechnology sector-related exchange traded fund stood out on better-than-expected quarterly earnings results and developing vaccines to combat the spreading coronavirus. The ARK Genomic Revolution Multi-Sector Fund...